BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Can-Fite BioPharma Ltd. 

Reinhold Cohn House
P.O.Box: 4060
Tel Aviv      Israel
Phone: 03-7109330 Fax: 03-5606405


SEARCH JOBS



Segment
Drug Discovery





 Company News
Can-Fite BioPharma (CFBI) To Present At The 9th International Congress Of Autoimmunity 3/25/2014 7:00:57 AM    More...
Can-Fite BioPharma (CFBI): Phase II Study Protocol To Treat Patients With Advanced Liver Cancer With CF102 Has Been Approved By The IRB In Israel 3/17/2014 9:57:25 AM    More...
Can-Fite BioPharma (CFBI) Completes $5 Million Private Placement 3/10/2014 12:31:56 PM    More...
Can-Fite BioPharma (CFBI) Announces the Addition Of A Key Opinion Leader To Boost Its Rheumatoid Arthritis CF101 Program 3/3/2014 6:55:13 AM    More...
Can-Fite BioPharma (CFBI)To Present At The 26th Annual ROTH Capital Conference 2/27/2014 6:41:42 AM    More...
Can-Fite BioPharma (CFBI) Granted Patent On The Manufacturing Of CF101 In Japan 2/25/2014 11:23:52 AM    More...
Can-Fite BioPharma (CFBI) Provides Update On Key Milestones For 2014 2/18/2014 9:43:42 AM    More...
Can-Fite BioPharma (CFBI) Comments On Global Rheumatoid Arthritis Market Opportunity 2/11/2014 9:49:37 AM    More...
Can-Fite BioPharma (CFBI) Submitted Phase II Study Protocol With CF102 To Treat Patients With Advanced Liver Cancer 2/6/2014 9:37:53 AM    More...
Can-Fite BioPharma (CFBI) To Present New Clinical Data From Further Analysis Of Its Clinical Studies Of CF101 For The Treatment Of Rheumatoid Arthritis And Psoriasis At Onemedforum And Biotech Showcase Held In San Francisco, California 1/13/2014 9:32:07 AM    More...
12345678910

//-->